Akanda Corp (NASDAQ:AKAN) — Market Cap & Net Worth
Market Cap & Net Worth: Akanda Corp (AKAN)
Akanda Corp (NASDAQ:AKAN) has a market capitalization of $1.51 Million ($1.51 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30372 globally and #6180 in its home market, demonstrating a -25.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akanda Corp's stock price $2.79 by its total outstanding shares 540841 (540.84K). Also see Akanda Corp total assets for a full breakdown of the balance sheet.
Akanda Corp Market Cap History: 2022 to 2026
Akanda Corp's market capitalization history from 2022 to 2026. Data shows change from $64.47 Million to $1.51 Million (-83.11% CAGR). Also see cash flow conversion of Akanda Corp for how efficiently the company converts equity into cash flow.
Index Memberships
Akanda Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #893 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2840 of 3165 |
Weight: Akanda Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akanda Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akanda Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check AKAN stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.96x
Akanda Corp's market cap is 0.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $64.47 Million | $2.62 Million | -$11.66 Million | 24.61x | N/A |
| 2023 | $19.06 Million | $2.16 Million | -$32.28 Million | 8.82x | N/A |
| 2024 | $865.35K | $836.66K | -$4.10 Million | 1.03x | N/A |
| 2025 | $247.33K | $258.07K | -$45.65 Million | 0.96x | N/A |
Competitor Companies of AKAN by Market Capitalization
Companies near Akanda Corp in the global market cap rankings as of September 18, 2026. Review Akanda Corp tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Akanda Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #519 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #640 | GALDERMA GROUP AG | NYSE:GALDY | $43.16 Billion | $37.02 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.62 Billion | CN¥43.52 |
Akanda Corp Historical Marketcap From 2022 to 2026
Between 2022 and today, Akanda Corp's market cap moved from $64.47 Million to $ 1.51 Million, with a yearly change of -83.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.51 Million | +510.10% |
| 2025 | $247.33K | -71.42% |
| 2024 | $865.35K | -95.46% |
| 2023 | $19.06 Million | -70.44% |
| 2022 | $64.47 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Akanda Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.51 Million USD |
| MoneyControl | $1.51 Million USD |
| MarketWatch | $1.51 Million USD |
| marketcap.company | $1.51 Million USD |
| Reuters | $1.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akanda Corp
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.